PharmaVoice Logo

Healthcare Leaders Hub

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 edition

Express Pharma

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 edition

Leucine Rich Bio has announced the launch of the upgraded BugSpeaks Skin Microbiome Test 2026 Edition. The company is ISO 9001:2015 and ISO/IEC 17025:2017 certified. The new report builds on […] The post Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 edition appeared first on Express Pharma.

Read Full Article
DIA India Annual Meeting 2026 to convene global and Indian healthcare leaders to shape the next era of innovation

Express Pharma

DIA India Annual Meeting 2026 to convene global and Indian healthcare leaders to shape the next era of innovation

The Drug Information Association (DIA) will bring together leaders from across the life sciences and healthcare ecosystem at the DIA India Annual Meeting (IAM) 2026, to be held on 18–19 […] The post DIA India Annual Meeting 2026 to convene global and Indian healthcare leaders to shape the next era of innovation appeared first on Express Pharma.

Read Full Article
FDA grants RMAT designation to RiboX’s RXRG001 for xerostomia

Pharma Tech

FDA grants RMAT designation to RiboX’s RXRG001 for xerostomia

The FDA has granted RMAT designation to RiboX Therapeutics’ investigational treatment RXRG001 for RIX and hyposalivation.

Read Full Article
CDSCO move towards smarter, risk-based regulation to ease doing business for Indian pharma: iPHEX 2026

Express Pharma

CDSCO move towards smarter, risk-based regulation to ease doing business for Indian pharma: iPHEX 2026

The Central Drugs Standard Control Organisation (CDSCO) is moving towards a smarter, risk-based regulatory approach that reduces and prioritises intervention, simplifies processes and applies greater proportionality to compliance, while continuing […] The post CDSCO move towards smarter, risk-based regulation to ease doing business for Indian pharma: iPHEX 2026 appeared first on Express Pharma.

Read Full Article
Fermenta Biotech signs exclusive licence agreement with VIT Vellore for vitamin B12 fortification technology

Express Pharma

Fermenta Biotech signs exclusive licence agreement with VIT Vellore for vitamin B12 fortification technology

Fermenta Biotech, India’s leading manufacturer of premium-grade APIs, intermediates, and nutritional premixes for the global markets, announced the signing of an Exclusive Licence Agreement with Vellore Institute of Technology (“VIT”), […] The post Fermenta Biotech signs exclusive licence agreement with VIT Vellore for vitamin B12 fortification technology appeared first on Express Pharma.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Express Pharma

Sep 9, 2026, 9:32 AM

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 edition

Leucine Rich Bio has announced the launch of the upgraded BugSpeaks Skin Microbiome Test 2026 Edition. The company is ISO 9001:2015 and ISO/IEC 17025:2017 certified. The new report builds on […] The post Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 edition appeared first on Express Pharma.

Express Pharma

Sep 9, 2026, 9:13 AM

DIA India Annual Meeting 2026 to convene global and Indian healthcare leaders to shape the next era of innovation

The Drug Information Association (DIA) will bring together leaders from across the life sciences and healthcare ecosystem at the DIA India Annual Meeting (IAM) 2026, to be held on 18–19 […] The post DIA India Annual Meeting 2026 to convene global and Indian healthcare leaders to shape the next era of innovation appeared first on Express Pharma.

Pharma Tech

Sep 9, 2026, 8:49 AM

FDA grants RMAT designation to RiboX’s RXRG001 for xerostomia

The FDA has granted RMAT designation to RiboX Therapeutics’ investigational treatment RXRG001 for RIX and hyposalivation.

PharmaShots

Sep 9, 2026, 8:30 AM

Pharvaris Reports the P-III (CHAPTER-3) Trial Data on Deucrictibant XR for Hereditary Angioedema (HAE)

Shots: Ref: Globenewswire | Image: Pharvaris  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Pharvaris Reports the P-III (CHAPTER-3) Trial Data on Deucrictibant XR for Hereditary Angioedema (HAE) appeared first on PharmaShots.

Express Pharma

Sep 9, 2026, 8:29 AM

CDSCO move towards smarter, risk-based regulation to ease doing business for Indian pharma: iPHEX 2026

The Central Drugs Standard Control Organisation (CDSCO) is moving towards a smarter, risk-based regulatory approach that reduces and prioritises intervention, simplifies processes and applies greater proportionality to compliance, while continuing […] The post CDSCO move towards smarter, risk-based regulation to ease doing business for Indian pharma: iPHEX 2026 appeared first on Express Pharma.

Express Pharma

Sep 9, 2026, 8:23 AM

Fermenta Biotech signs exclusive licence agreement with VIT Vellore for vitamin B12 fortification technology

Fermenta Biotech, India’s leading manufacturer of premium-grade APIs, intermediates, and nutritional premixes for the global markets, announced the signing of an Exclusive Licence Agreement with Vellore Institute of Technology (“VIT”), […] The post Fermenta Biotech signs exclusive licence agreement with VIT Vellore for vitamin B12 fortification technology appeared first on Express Pharma.

News

Latest industry coverage

Google News

Sep 9, 2026, 9:02 AM

Some People Stay Well, Others Get Sick: Could Resilience Guide Drug Discovery? - Technology Networks

Some People Stay Well, Others Get Sick: Could Resilience Guide Drug Discovery?  Technology Networks

Google News

Sep 9, 2026, 9:00 AM

Pharma giant Merck to slash 54 jobs at Rahway headquarters - ROI-NJ

Pharma giant Merck to slash 54 jobs at Rahway headquarters  ROI-NJ

Google News

Sep 9, 2026, 9:00 AM

Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities - Business Wire

Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities  Business Wire

Google News

Sep 9, 2026, 8:30 AM

Scientists and algorithms: Finding the right balance in modern drug development - pharmaphorum

Scientists and algorithms: Finding the right balance in modern drug development  pharmaphorum

Google News

Sep 9, 2026, 8:29 AM

India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth - NDTV Profit

India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth  NDTV Profit

Google News

Sep 9, 2026, 8:26 AM

MIPS in Udaipur: India's largest Pharma College building & Tripura's first women-centric campus - Tripuratimes

MIPS in Udaipur: India's largest Pharma College building & Tripura's first women-centric campus  Tripuratimes

Google News

Sep 9, 2026, 8:12 AM

Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031 - The Globe and Mail

Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031  The Globe and Mail

Google News

Sep 9, 2026, 7:56 AM

Scientific Innovation and Manufacturing to Drive India’s Speciality Pharma Growth - The Indian Practitioner

Scientific Innovation and Manufacturing to Drive India’s Speciality Pharma Growth  The Indian Practitioner

Google News

Sep 9, 2026, 7:54 AM

Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031 - The Motley Fool

Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031  The Motley Fool

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer